Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Middle Aged. Found 362 abstracts

no pagination
Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018 Jan;41(1):59-64.   PMCID: PMC4769977
Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug;98(5):1028-35.   PMCID: PMC5572128
Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 Sep 26;18(11):1483-92.
Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection. Am J Clin Oncol. 2017 Aug;40(4):393-8.   PMCID: PMC5026539
Choueiri TK, Plimack E, Arkenau HT, Jonasch E, Heng DY, Powles T, Frigault MM, Clark EA, Handzel AA, Gardner H, Morgan S, Albiges L, Pal SK. Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer. J Clin Oncol. 2017 Sep 10;35(26):2993-3001.
Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. Breast J. 2017 Mar;23(2):169-76.
Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evans A, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 Nov 15;123(22):4411-8.
Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters M, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DS, Wang HJ, Elashoff DA, Elashoff RM. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. The New England journal of medicine. 2017 Jun 08;376(23):2211-22.   PMCID: PMC5548388
Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Anti-Mullerian hormone and endometrial cancer: a multi-cohort study. Br J Cancer. 2017 Oct 24;117(9):1412-8.   PMCID: PMC5672934
Gore JL, du Plessis M, Santiago-Jimenez M, Yousefi K, Thompson DJ, Karsh L, Lane BR, Franks M, Chen DY, Bandyk M, Bianco FJ, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW. Decipher Test Impacts Decision Making Among Patients Considering Adjuvant and Salvage Treatment After Radical Prostatectomy: Interim Results From the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-9.   PMCID: PMC5573983
Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep;3(9):1249-52.   PMCID: PMC5591751
Hellmann MD, Rizvi NA, Goldman JW, Gettinger SN, Borghaei H, Brahmer JR, Ready NE, Gerber DE, Chow LQ, Juergens RA, Shepherd FA, Laurie SA, Geese WJ, Agrawal S, Young TC, Li X, Antonia SJ. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Lancet Oncol. 2017 Jan;18(1):31-41.   PMCID: PMC5476941
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197
Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sanchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjonneland A, Trichopoulou A, Tworoger S, Visvanathan K, Krogh V, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF. Demographic, lifestyle, and other factors in relation to antimullerian hormone levels in mostly late premenopausal women. Fertility and sterility. 2017 Apr;107(4):1012-1022 e2.   PMCID: PMC5426228
Kantarjian HM, Roboz GJ, Kropf PL, Yee KW, O'Connell CL, Tibes R, Walsh KJ, Podoltsev NA, Griffiths EA, Jabbour E, Garcia-Manero G, Rizzieri D, Stock W, Savona MR, Rosenblat TL, Berdeja JG, Ravandi F, Rock EP, Hao Y, Azab M, Issa JJ. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Lancet Oncol. 2017 Aug 24;18(10):1317-26.
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, Brca, Brca Cohort Consortium, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 2017 Jun 20;317(23):2402-16.
Kuchenbaecker KB, McGuffog L, Barrowdale D, Lee A, Soucy P, Dennis J, Domchek SM, Robson M, Spurdle AB, Ramus SJ, Mavaddat N, Terry MB, Neuhausen SL, Schmutzler RK, Simard J, Pharoah PD, Offit K, Couch FJ, Chenevix-Trench G, Easton DF, Antoniou AC, Lush M, Hamann U, Southey M, John EM, Chung WK, Daly MB, Buys SS, Goldgar DE, Dorfling CM, van Rensburg EJ, Chun Ding Y, Ejlertsen B, Gerdes AM, Hansen TV, Slager S, Hallberg E, Benitez J, Osorio A, Cohen N, Lawler W, Weitzel JN, Peterlongo P, Pensotti V, Dolcetti R, Barile M, Bonanni B, Azzollini J, Manoukian S, Peissel B, Radice P, Savarese A, Papi L, Giannini G, Fostira F, Konstantopoulou I, Adlard J, Brewer C, Cook J, Davidson R, Eccles D, Eeles R, Ellis S, Frost D, Hodgson S, Izatt L, Lalloo F, Ong KR, Godwin AK, Arnold N, Dworniczak B, Engel C, Gehrig A, Hahnen E, Hauke J, Kast K, Meindl A, Niederacher D, Schmutzler RK, Varon-Mateeva R, Wang-Gohrke S, Wappenschmidt B, Barjhoux L, Collonge-Rame MA, Elan C, Golmard L, Barouk-Simonet E, Lesueur F, Mazoyer S, Sokolowska J, Stoppa-Lyonnet D, Isaacs C, Claes KB, Poppe B, de la Hoya M, Garcia-Barberan V, Aittomaki K, Nevanlinna H, Ausems M, de Lange JL, Gomez Garcia EB, Hogervorst FB, Kets CM, Meijers-Heijboer HE, Oosterwijk JC, Rookus MA, van Asperen CJ, van den Ouweland AM, van Doorn HC, van Os TA, Kwong A, Olah E, Diez O, Brunet J, Lazaro C, Teule A, Gronwald J, Jakubowska A, Kaczmarek K, Lubinski J, Sukiennicki G, Barkardottir RB, Chiquette J, Agata S, Montagna M, Teixeira MR, Kyung Park S, Olswold C, Tischkowitz M, Foretova L, Gaddam P, Vijai J, Pfeiler G, Rappaport-Fuerhauser C, Singer CF, Tea MK, Greene MH, Loud JT, Rennert G, Imyanitov EN, Hulick PJ, Hays JL, Piedmonte M, Rodriguez GC, Martyn J, Glendon G, Mulligan AM, Andrulis IL, Toland AE, Jenson UB, Kruse TA, Sokilde Pedersen I, Thomassen M, Caligo MA, Teo SH, Berger R, Friedman E, Laitman Y, Arver B, Borg A, Ehrancrona H, Rantala J, Olopade OI, Ganz PA, Nussbaum RL, Bradbury AR, Domchek SM, Nathanson KL, Arun BK, James P, Karlan BY, Lester J, Simard J, Pharoah PD, Offit K, Couch FJ, Chenevix-Trench G, Easton DF, Antoniou AC. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute. 2017 Jul;109(7).   PMCID: PMC5408990
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Lazar AJ, McLellan MD, Bailey MH, Miller CA, Appelbaum EL, Cordes MG, Fronick CC, Fulton LA, Fulton RS, Mardis ER, Schmidt HK, Wong W, Wilson RK, Yellapantula V, Radenbaugh AJ, Hoadley KA, Hayes DN, Parker JS, Wilkerson MD, Auma JT, Balu S, Bodenheimer T, Hoyle AP, Jefferys SR, Jones CD, Lehmann KV, Meng SW, Mieczkowski PA, Mose LE, Perou CM, Roach J, Senbabaoglu Y, Shi Y, Simons JV, Skelly T, Soloway MG, Tan DH, Veluvolu U, Davis IJ, Hepperla AJ, Brohl AS, Kasaian K, Mungall K, Sadeghi S, Barthel FP, Verhaak R, Hu X, Chibon F, Cherniack AD, Shih J, Beroukhim R, Meyerson M, Cibulskis C, Gabriel SB, Saksena G, Schumacher SE, Bailey MH, Gao QS, Wong WH, Wyczalkowski M, Bowlby R, Robertson AG, Ally A, Balasundaram M, Brooks D, Carlsen R, Chuah E, Dhalla N, Holt RA, Jones SJ, Lee D, Li I, Ma Y, Marra MA, Mayo M, Moore RA, Mungall AJ, Parker JS, Schein JE, Sipahimalani P, Tam A, Thiessen N, Wong T, Danilova L, Cope L, Baylin SB, Bootwalla MS, Lai PH, Laird PW, Maglinte DT, Van Den Berg DJ, Weisenberger DJ, Wrangle J, Drill E, Shen RL, Iype L, Reynolds SM, Shmulevich I, Yau C, Armenia J, Liu EM, Benz C, Pastore A, Sanchez-Vega F, Schultz N, Akbani R, Hegde AM, Liu WB, Lu Y, Mills GB, Weinstein JN, Roszik J, Anur P, Spellman P, Abeshouse A, Chen HW, Gao J, Heins Z, Kundra R, Larsson E, Ochoa A, Sanchez-Vega F, Sander C, Schultz N, Socci N, Zhang HX, Noble MS, Heiman DI, Kim J, Chin L, Getz G, Cho J, Defreitas T, Frazer S, Gehlenborg N, Lawrence MS, Lin P, Meier S, Voet D, Zhang HL, Byers L, Diao LX, Gay CM, Wang J, Newton Y, Cooper LA, Gutman DA, Lazar AJ, Lee S, Nalisnik M, Bowen J, Gastier-Foster JM, Gerken M, Helsel C, Hobensack S, Leraas KM, Lichtenberg TM, Ramirez NC, Wise L, Zmuda E, Anderson ML, Castro P, Ittmann M, Gordienko E, Paklina O, Setdikova G, Raut CP, Karlan BY, Lester J, Belyaev D, Fulidou V, Potapova O, Voronina O, Demetri GD, Ramalingam SS, Behera M, Delman K, Owonikoko TK, Sica GL, Boyd J, Magliocco A, Salner A, Bennett J, Iacocca M, Swanson P, Dottino P, Kalir T, Pereira E, Akeredolu T, Crain D, Curley E, Gardner J, Mallery D, Morris S, Paulauskis J, Penny R, Shelton C, Shelton T, Thompson E, Hoon DB, Parfitt J, Birrer M, Karseladze A, Mariamidze A, Dao F, Levine DA, Olvera N, Maki RG, Bartlett J, Eschbacher J, Dubina M, Mozgovoy E, Fedosenko K, Manikhas G, Sekhon H, Ramirez N, Lazar AJ, Ingram DR, Torres KE, DiSaia P, Godwin AK, Godwin EM, Kuo H, Madan R, Reilly C, Adebamowo C, Adebamowo SN, Bocklage T, Higgins K, Martinez C, Auman JT, Boice L, Grilley-Olson JE, Huang M, Perou AH, Thorne LB, Rathmell WK, Gutmann DH, Singer S, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan YH, Wu Y, Felau I, Zenklusen JC, Demchok JA, Ferguson ML, Hutter CM, Sofia HJ, Tarnuzzer R, Wang ZN, Yang LM, Zhang JS, Demicco EG, Doyle LA, Hornick JL, Lazar AJ, Rubin BP, de Rijn MV, Demetri GD, Baker L, Grilley-Olson JE, Iype L, Lazar AJ, Lichtenberg TM, Raut CP, Riedel RF, Demicco EG, Ding L, Ladanyi M, Lazar AJ, Novak JE, Sanchez-Vega F, Singer S, Van Tine BA, Byers L, Cope L, Cherniack AD, Cooper LA, Davis IJ, Davis LE, Demetri GD, Doyle LA, Drill E, Godwin AK, Grilley-Olsen JE, Gutmann DH, Hayes DN, Hepperla AJ, Hoadley KA, Hoon DB, Hornick JL, Iype L, Kim J, Maki RG, Pollock RE, Raut CP, Riedel RF, Robertson AG, Rubin BP, Shih J, Weinstein JN, Wong WH, Akbani R, Anderson ML, Anur P, Bailey MH, Benz C, Bowen J, Bowlby R, Brohl AS, Cherniack AD, Cooper LA, Cope L, Danilova L, Davis LE, Demetri GD, Gay CM, Godwin AK, Grilley-Olson JE, Gutman DA, Hegde AM, Jones KB, Kasaian K, Ladanyi M, Lazar AJ, Lee S, Leraas KM, Lichtenberg TM, Martignetti JA, McLellan MD, Miller CA, Mungall K, Nalisnik M, Noble MS, Raut CP, Riedel RF, Robertson AG, Roszik J, Sadeghi S, Sanchez-Vega F, Shen RL, Shih J, Tong P, Torres KE, Yau C, Zenklusen JC, Canc Genome Atlas Res N. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell. 2017 Nov;171(4):950-965 e28.   PMCID: PMC5693358
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Middle Aged

Middle Aged Aged pathology Adult Female Disease-Free Survival Male therapeutic use 80 and over Aged Neoplasm Staging adverse effects Prospective Studies administration & dosage mortality Young Adult Prognosis drug therapy methods therapy Risk Assessment genetics surgery Treatment Outcome Adenocarcinoma statistics & numerical data blood Follow-Up Studies Survival Analysis diagnosis Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Age Factors Multivariate Analysis Survival Rate Kaplan-Meier Estimate Neoplasm Invasiveness Drug Administration Schedule metabolism Mutation United States Proportional Hazards Models analogs & derivatives Drug Dose-Response Relationship Prostatic Neoplasms Salvage Therapy Intensity-Modulated Radiotherapy Risk Factors Cohort Studies BRCA2 Genes Androgen Antagonists Time Factors Radiation Injuries Double-Blind Method Conformal Radiotherapy Incidence radiotherapy Prostatectomy Ovarian Neoplasms BRCA1 Genes Tumor Biomarkers Intravenous Infusions Antineoplastic Agents Carboplatin Renal Cell Carcinoma Prostate-Specific Antigen secondary Patient Safety Europe Maximum Tolerated Dose enzymology etiology Neoplasm Grading diagnostic imaging Segmental Mastectomy Adolescent Lung Neoplasms Kidney Neoplasms Retrospective Studies epidemiology Anti-Mullerian Hormone Remission Induction Medicaid Flutamide Transitional Cell Carcinoma Lymphedema Adjuvant Chemoradiotherapy Local Neoplasm Recurrence non-Hodgkin lymphoma Asia Non-Small-Cell Lung Carcinoma SEER Program genomics Pancreatic Neoplasms Hematopoietic Stem Cell Transplantation Taxoids Piperidines demographic Cross-Sectional Studies Dinoprostone breast cancer undifferentiated pleomorphic sarcoma Anilides postprostatectomy Testosterone Congeners Registries Sarcoma chemotherapy Intraductal Carcinoma-Noninfiltrating DNA methylation Pyrroles Fibrosis Premenopause Multifactorial Inheritance Paclitaxel Sentinel Lymph Node Celecoxib Enzyme-Linked Immunosorbent Assay Radiation Oncology leiomyosarcoma biosynthesis Insurance Coverage myxofibrosarcoma Myeloid Leukemia-Acute myc Genes physiopathology Oral Administration Age Distribution adjuvant therapy Ovarian Reserve Lymph Nodes Reoperation hematopoietic cell transplantation (HCT) Quinazolines Fluorouracil Case-Control Studies Neoplasm Drug Resistance Predictive Value of Tests Internationality molecular subtype Pemetrexed radiation effects androgen deprivation Health Insurance diffuse large B-cell lymphoma (DLBCL) Gonadotropin-Releasing Hormone Postoperative Complications Estrogen Receptors Biomarkers Watchful Waiting docetaxel
Last updated on Friday, January 05, 2018